Autologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPC
Clinical trial NCT03085966 · UNKNOWN
Trial details
- NCT number
- NCT03085966
- Sponsor
- Shanghai AbelZeta Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-27
- Primary completion
- 2019-10-27
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.